3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Head & Neck
1
Gynecologic
1
Gastrointestinal
1
Dermatologic
1
CNS
1
Breast
1
Conditions
Ovarian Neoplasms
1
Neoplasm Metastasis
1
Melanoma
1
Lung Neoplasms
1
Head and Neck Neoplasms
1
Gastrointestinal Neoplasms
1
Breast Neoplasms
1
Brain Neoplasms
1
Interventions
pembrolizumab
22
Nivolumab
17
Magnetic Resonance Spectroscopy
12
Specimen Handling
10
Cyclophosphamide
9
Radiosurgery
7
Drug Therapy
6
Radiotherapy
5
Paclitaxel
5
Ipilimumab
5
fludarabine
4
Biopsy
4
trametinib
3
sargramostim
3
Trastuzumab
3
Taxes
3
Pemetrexed
3
Metformin
3
Interleukin-2
3
Immunoglobulin G
3
Gemcitabine
3
Carboplatin
3
Bevacizumab
3
tremelimumab
2
temsirolimus
2
poly ICLC
2
pertuzumab
2
osimertinib
2
motexafin gadolinium
2
epacadostat
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Lung Neoplasms
×
Patient-Specific Modeling
×
Dermatologic
×
Clear all
NCT02000739
2014-07-14
GENIUS
Dartmouth-Hitchcock Medical Center
Phase 4
Withdrawn